"ASSOCIATION_TYPE"	"PMID"	"NUM_SENTENCE"	"ENTITY1_TEXT"	"ENTITY1_INI"	"ENTITY1_END"	"ENTITY1_TYPE"	"ENTITY2_TEXT"	"ENTITY2_INI"	"ENTITY2_END"	"ENTITY2_TYPE"	"SENTENCE"
"SA"	17241106	16	"LRP5"	19	23	"Genes & Molecular Sequences"	"osteoporosis"	80	92	"Diseases & Disorders"	"Our work supported LRP5 genetic variants as possible susceptibility factors for osteoporosis and fractures in humans."
"SA"	17241106	17	"rs491347"	20	28	"SNP & Sequence variations"	"osteoporosis"	108	120	"Diseases & Disorders"	"Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes."
"SA"	17241106	17	"rs1784235"	69	78	"SNP & Sequence variations"	"osteoporosis"	108	120	"Diseases & Disorders"	"Especially, the SNP rs491347 and its strongly associated SNPs (e.g., rs1784235) could be important to human osteoporosis phenotypes."
"FA"	18697826	0	"fetal haemoglobin"	93	110	"Genes & Molecular Sequences"	"beta-thalassaemia"	132	149	"Diseases & Disorders"	"The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia."
"PA"	18697826	1	"HbF"	19	22	"Genes & Molecular Sequences"	"HBB disorders"	64	77	"Diseases & Disorders"	"Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders."
"PA"	18697826	1	"Fetal haemoglobin"	0	17	"Genes & Molecular Sequences"	"HBB disorders"	64	77	"Diseases & Disorders"	"Fetal haemoglobin (HbF) level modifies the clinical severity of HBB disorders."
"FA"	18697826	0	"HBS1L-MYB"	4	13	"Genes & Molecular Sequences"	"beta-thalassaemia"	132	149	"Diseases & Disorders"	"The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia."
"FA"	18697826	0	"6q23"	46	50	"Genes & Molecular Sequences"	"beta-thalassaemia"	132	149	"Diseases & Disorders"	"The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia."
"FA"	18697826	7	"HbF"	87	90	"Genes & Molecular Sequences"	"HBB disorders"	196	209	"Diseases & Disorders"	"Functional studies to unravel the biological significance of this region in regulating HbF production is clearly indicated, which may lead to new strategies to modify the disease course of severe HBB disorders."
"PA"	18322311	0	"TNFalpha gene polymorphisms"	16	43	"Genes & Molecular Sequences"	"multiple sclerosis"	69	87	"Diseases & Disorders"	"IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis."
"FA"	18322311	7	"IL-1alpha TT -889"	35	52	"SNP & Sequence variations"	"multiple sclerosis"	406	424	"Diseases & Disorders"	"On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients."
"PA"	18322311	7	"TNFalpha G -308 allele"	138	160	"Genes & Molecular Sequences"	"multiple sclerosis"	406	424	"Diseases & Disorders"	"On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian multiple sclerosis patients."
"PA"	18322311	0	"IL-1"	0	4	"Genes & Molecular Sequences"	"multiple sclerosis"	69	87	"Diseases & Disorders"	"IL-1, IL-1R and TNFalpha gene polymorphisms in Iranian patients with multiple sclerosis."
"PA"	18347176	0	"T393C polymorphism of the GNAS1"	127	158	"SNP & Sequence variations"	"oropharyngeal"	37	50	"Diseases & Disorders"	"Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene."
"PA"	18347176	0	"T393C polymorphism of the GNAS1"	127	158	"SNP & Sequence variations"	"hypopharyngeal squamous cell carcinoma"	55	93	"Diseases & Disorders"	"Overall and relapse-free survival in oropharyngeal and hypopharyngeal squamous cell carcinoma are associated with genotypes of T393C polymorphism of the GNAS1 gene."
"FA"	18347176	9	"T393C"	4	9	"SNP & Sequence variations"	"hypopharyngeal cancer"	130	151	"Diseases & Disorders"	"The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer."
"PA"	18347176	9	"T393C"	4	9	"SNP & Sequence variations"	"oropharyngeal"	112	125	"Diseases & Disorders"	"The T393C SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and hypopharyngeal cancer."
"FA"	18347176	3	"T393C"	28	33	"SNP & Sequence variations"	"oropharyngeal"	121	134	"Diseases & Disorders"	"The prognostic value of the T393C SNP was evaluated in an unselected series of patients treated with curative intent for oropharyngeal and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens."
"FA"	17430902	3	"Wnt"	69	72	"Genes & Molecular Sequences"	"colon cancer"	25	37	"Diseases & Disorders"	"However, the majority of colon cancer cells have deregulation of the Wnt/beta-catenin pathway."
"FA"	17430902	0	"Krüppel-like factor 5"	87	108	"Genes & Molecular Sequences"	"colon cancer"	51	63	"Diseases & Disorders"	"Lysophosphatidic acid facilitates proliferation of colon cancer cells via induction of Krüppel-like factor 5."
"PA"	17430902	2	"beta-catenin"	99	111	"Genes & Molecular Sequences"	"colon cancer"	57	69	"Diseases & Disorders"	"A recent study showed that LPA-mediated proliferation of colon cancer cells requires activation of beta-catenin."
"PA"	18930278	6	"CYP3A5 A6986G genotype *3/*3"	29	57	"Genes & Molecular Sequences"	"leukocytopenia"	211	225	"Diseases & Disorders"	"On multivariate analysis the CYP3A5 A6986G genotype *3/*3 (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for leukocytopenia (grade 3 or greater) throughout the period of chemotherapy."
"PA"	18930278	8	"A6986G polymorphism of CYP3A5"	4	33	"Genes & Molecular Sequences"	"leukocytopenia"	151	165	"Diseases & Disorders"	"The A6986G polymorphism of CYP3A5, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of leukocytopenia induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin."
"SA"	17593927	11	"XRCC1"	0	5	"Genes & Molecular Sequences"	"gastric cancer"	61	75	"Diseases & Disorders"	"XRCC1 genotyping might make tailor chemotherapy possible for gastric cancer patients treated with oxaliplatin-based chemotherapy."
"PA"	17593927	0	"Polymorphism of XRCC1"	0	21	"Genes & Molecular Sequences"	"gastric cancer"	51	65	"Diseases & Disorders"	"Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population."
"PA"	19097922	1	"CYP4F2"	45	51	"Genes & Molecular Sequences"	"myocardial infarction"	61	82	"Diseases & Disorders"	"This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200)."
"PA"	19097922	0	"CYP4F2"	19	25	"Genes & Molecular Sequences"	"myocardial infarction"	47	68	"Diseases & Disorders"	"A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men."
"PA"	19097922	2	"rs2108622"	31	40	"SNP & Sequence variations"	"MI"	170	172	"Diseases & Disorders"	"For men, G allele frequency of rs2108622 and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for MI patients than for controls (P=0.006, P=0.001 and P=0.002, respectively)."
"FA"	19097922	1	"CYP4F2"	45	51	"Genes & Molecular Sequences"	"MI"	139	141	"Diseases & Disorders"	"This study assessed associations between the CYP4F2 gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200)."
"PA"	17631643	6	"ALDH2 Ex1+82A>G"	19	34	"Genes & Molecular Sequences"	"stomach cancer"	78	92	"Diseases & Disorders"	"When stratified by ALDH2 Ex1+82A>G polymorphism, alcohol-related increases in stomach cancer risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years."
"PA"	19035720	1	"COL1A2"	4	10	"Genes & Molecular Sequences"	"IAs"	96	99	"Diseases & Disorders"	"The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population."
"PA"	19035720	1	"COL1A2"	4	10	"Genes & Molecular Sequences"	"intracranial aneurysms"	72	94	"Diseases & Disorders"	"The COL1A2 gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (IAs) in the Japanese population."
"SA"	19035720	6	"rs42524"	4	11	"SNP & Sequence variations"	"IAs"	79	82	"Diseases & Disorders"	"The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity."
"FA"	19035720	2	"COL1A2"	115	121	"Genes & Molecular Sequences"	"IAs"	153	156	"Diseases & Disorders"	"In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in COL1A2 and the occurrence of sporadic IAs in Chinese patients."
"PA"	19035720	7	"COL1A2"	59	65	"Genes & Molecular Sequences"	"IAs"	70	73	"Diseases & Disorders"	"This study is the first to confirm the association between COL1A2 and IAs."
"FA"	19035720	6	"COL1A2"	28	34	"Genes & Molecular Sequences"	"IAs"	79	82	"Diseases & Disorders"	"The rs42524 polymorphism of COL1A2 could be a genetic risk factor for sporadic IAs among individuals of Chinese Han ethnicity."
"FA"	17548585	6	"TLR"	133	136	"Genes & Molecular Sequences"	"leprosy"	74	81	"Diseases & Disorders"	"Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion."
"PA"	17548585	0	"TLR1"	97	101	"Genes & Molecular Sequences"	"leprosy"	123	130	"Diseases & Disorders"	"Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy."
"PA"	17548585	6	"602S"	18	22	"SNP & Sequence variations"	"leprosy"	74	81	"Diseases & Disorders"	"Surprisingly, the 602S allele is associated with a decreased incidence of leprosy, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion."
"PA"	17186014	10	"TRAIL"	64	69	"Genes & Molecular Sequences"	"prostate cancer"	138	153	"Diseases & Disorders"	"These results suggest that combination of HDACi with adenoviral TRAIL gene therapy may be a new therapeutic approach for the treatment of prostate cancer that warrants further investigation."
"PA"	17433748	0	"ALDH7A1"	85	92	"Genes & Molecular Sequences"	"pyridoxine dependent seizures"	43	72	"Diseases & Disorders"	"Allelic and non-allelic heterogeneities in pyridoxine dependent seizures revealed by ALDH7A1 mutational analysis."
"FA"	17433748	2	"ALDH7A1"	48	55	"Genes & Molecular Sequences"	"PDS"	88	91	"Diseases & Disorders"	"Recently, mutations have been identified in the ALDH7A1 gene in Caucasian families with PDS."
"PA"	19110417	1	"Cytochrome P450 1A1"	0	19	"Genes & Molecular Sequences"	"hepatocellular carcinoma"	90	114	"Diseases & Disorders"	"Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC)."
"SA"	19110417	2	"CYP1A1"	56	62	"Genes & Molecular Sequences"	"HCC"	70	73	"Diseases & Disorders"	"However, the contribution of common genetic variants in CYP1A1 to the HCC risk in Chinese populations has not been thoroughly investigated."
"PA"	19110417	1	"Cytochrome P450 1A1"	0	19	"Genes & Molecular Sequences"	"HCC"	116	119	"Diseases & Disorders"	"Cytochrome P450 1A1 is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (HCC)."
"PA"	19110417	10	"TTAC/CCAG"	29	38	"SNP & Sequence variations"	"HCC"	75	78	"Diseases & Disorders"	"Interestingly, the diplotype TTAC/CCAG also conferred an increased risk of HCC (OR 1.76, 95% CI 1.22-2.54, P=0.003)."
"PA"	19110417	6	"rs2198843"	110	119	"SNP & Sequence variations"	"HCC"	188	191	"Diseases & Disorders"	"To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant."
"PA"	19110417	6	"rs4886605"	259	268	"SNP & Sequence variations"	"HCC"	188	191	"Diseases & Disorders"	"To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of HCC (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant."
"FA"	19110417	8	"CYP1A1"	28	34	"Genes & Molecular Sequences"	"HCC"	101	104	"Diseases & Disorders"	"Compared to the most common CYP1A1 haplotype CCAG, the haplotype TTGC conferred an increased risk of HCC (OR 1.26, 95% CI 1.04-1.52)."
"FA"	19110417	3	"CYP1A1"	147	153	"Genes & Molecular Sequences"	"HCC"	209	212	"Diseases & Disorders"	"In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of CYP1A1 haplotypes/diplotypes in 1006 pathologically confirmed HCC patients and 1015 cancer-free controls, from a Han Chinese population."
"SA"	19110417	11	"CYP1A1"	54	60	"Genes & Molecular Sequences"	"HCC"	97	100	"Diseases & Disorders"	"Our results suggested that common genetic variants in CYP1A1 may modulate the risk of developing HCC in the study population, particularly in non-smokers."
"PA"	17582399	1	"Amyloid beta protein"	0	20	"Genes & Molecular Sequences"	"Alzheimer's disease"	65	84	"Diseases & Disorders"	"Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients."
"PA"	17582399	1	"Abeta"	22	27	"Genes & Molecular Sequences"	"Alzheimer's disease"	65	84	"Diseases & Disorders"	"Amyloid beta protein (Abeta) levels are elevated in the brain of Alzheimer's disease patients."
"FA"	17582399	0	"amyloid beta protein"	5	25	"Genes & Molecular Sequences"	"Alzheimer's disease"	102	121	"Diseases & Disorders"	"Anti-amyloid beta protein antibody passage across the blood-brain barrier in the SAMP8 mouse model of Alzheimer's disease: an age-related selective uptake with reversal of learning impairment."
"PA"	18381438	1	"p53"	260	263	"Genes & Molecular Sequences"	"solid tumors"	175	187	"Diseases & Disorders"	"The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced solid tumors indicate that patients whose tumors were wild-type, but not mutant, for p53 obtained the most clinical benefit from this combination therapy."
"FA"	17589947	1	"TNF)-alpha"	223	233	"Genes & Molecular Sequences"	"IBD"	290	293	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"FA"	17589947	1	"TNF)-alpha"	223	233	"Genes & Molecular Sequences"	"inflammatory bowel diseases"	261	288	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"PA"	17589947	4	"TIMP-1 genotype TT"	4	22	"Genes & Molecular Sequences"	"CD"	83	85	"Diseases & Disorders"	"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025)."
"PA"	17589947	4	"TIMP-1 genotype TT"	4	22	"Genes & Molecular Sequences"	"fistulae"	237	245	"Diseases & Disorders"	"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025)."
"PA"	17589947	6	"5T5T genotype at MMP-3 SNP -1613 5T/6T"	4	42	"SNP & Sequence variations"	"CD"	93	95	"Diseases & Disorders"	"The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017)."
"PA"	17589947	7	"TIMP-1"	61	67	"Genes & Molecular Sequences"	"CD"	85	87	"Diseases & Disorders"	"Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation."
"PA"	17589947	7	"MMP-3"	72	77	"Genes & Molecular Sequences"	"CD"	85	87	"Diseases & Disorders"	"Allelic composition at the examined SNPs in genes coding for TIMP-1 and MMP-3 affect CD susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation."
"FA"	17589947	1	"tissue inhibitors of metalloproteinases"	143	182	"Genes & Molecular Sequences"	"IBD"	290	293	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"FA"	17589947	1	"tissue inhibitors of metalloproteinases"	143	182	"Genes & Molecular Sequences"	"inflammatory bowel diseases"	261	288	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"PA"	17589947	1	"tumor necrosis factor"	200	221	"Genes & Molecular Sequences"	"inflammatory bowel diseases"	261	288	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"FA"	17589947	1	"tumor necrosis factor"	200	221	"Genes & Molecular Sequences"	"IBD"	290	293	"Diseases & Disorders"	"To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (IBD), that may enhance susceptibility and/or disease severity."
"FA"	17589947	4	"SNP +372 T/C"	48	60	"SNP & Sequence variations"	"fistulae"	237	245	"Diseases & Disorders"	"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025)."
"PA"	17589947	4	"SNP +372 T/C"	48	60	"SNP & Sequence variations"	"CD"	83	85	"Diseases & Disorders"	"The TIMP-1 genotype TT in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025)."
"FA"	17589947	6	"MMP-3"	21	26	"Genes & Molecular Sequences"	"CD"	93	95	"Diseases & Disorders"	"The 5T5T genotype at MMP-3 SNP -1613 5T/6T increased the chance of stenotic complications in CD during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017)."
"PA"	17096334	0	"NPAS2"	41	46	"Genes & Molecular Sequences"	"non-Hodgkin's lymphoma"	85	107	"Diseases & Disorders"	"Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma."
"FA"	17096334	0	"Ala394Thr"	0	9	"SNP & Sequence variations"	"non-Hodgkin's lymphoma"	85	107	"Diseases & Disorders"	"Ala394Thr polymorphism in the clock gene NPAS2: a circadian modifier for the risk of non-Hodgkin's lymphoma."
"PA"	18071766	4	"stx2"	22	26	"Genes & Molecular Sequences"	"HUS"	118	121	"Diseases & Disorders"	"STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha."
"PA"	18071766	4	"stx2"	22	26	"Genes & Molecular Sequences"	"hemolytic-uremic syndrome"	91	116	"Diseases & Disorders"	"STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha."
"PA"	18071766	4	"stx2"	22	26	"Genes & Molecular Sequences"	"bloody diarrhea"	126	141	"Diseases & Disorders"	"STEC strains carrying stx2 were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or bloody diarrhea than those carrying stx2vha."
"PA"	18071766	6	"stx2"	157	161	"Genes & Molecular Sequences"	"STEC O157 infection"	85	104	"Diseases & Disorders"	"We conclude that stx genotype is one of the important factors of clinical outcome of STEC O157 infection and that pathogenicity for humans was higher in the stx2 genotype strains than in the stx2vha genotype strains, as reported previously by other researchers."
"PA"	17258816	5	"ME2"	81	84	"Genes & Molecular Sequences"	"psychosis"	158	167	"Diseases & Disorders"	"Subsequent analysis of individual SNPs in strong linkage disequilibrium with the ME2 gene revealed one SNP and one haplotype associated with the phenotype of psychosis in the CVCR sample."
"PA"	17258816	6	"ME2"	0	3	"Genes & Molecular Sequences"	"bipolar disorder"	111	127	"Diseases & Disorders"	"ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid."
"PA"	17258816	6	"ME2"	0	3	"Genes & Molecular Sequences"	"schizophrenia"	93	106	"Diseases & Disorders"	"ME2 interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid."
"PA"	17258816	7	"ME2"	65	68	"Genes & Molecular Sequences"	"psychotic"	98	107	"Diseases & Disorders"	"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder."
"PA"	17258816	7	"ME2"	65	68	"Genes & Molecular Sequences"	"manic disorders"	112	127	"Diseases & Disorders"	"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder."
"PA"	17258816	7	"ME2"	65	68	"Genes & Molecular Sequences"	"schizophrenia"	139	152	"Diseases & Disorders"	"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder."
"PA"	17258816	7	"ME2"	65	68	"Genes & Molecular Sequences"	"bipolar disorder"	157	173	"Diseases & Disorders"	"The present study suggests that genetic variation in or near the ME2 gene is associated with both psychotic and manic disorders, including schizophrenia and bipolar disorder."
"PA"	17270229	2	"p53"	31	34	"Genes & Molecular Sequences"	"cancers"	159	166	"Diseases & Disorders"	"Genetic alterations within the p53 gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all cancers."
"PA"	17270229	5	"p53"	34	37	"Genes & Molecular Sequences"	"non-melanoma skin cancers"	108	133	"Diseases & Disorders"	"This review discusses the role of p53 from normal function and its dysfunction in pre-cancerous lesions and non-melanoma skin cancers."
"PA"	19100387	1	"CRP"	137	140	"Genes & Molecular Sequences"	"CKD"	175	178	"Diseases & Disorders"	"We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation."
"PA"	19100387	1	"CRP"	137	140	"Genes & Molecular Sequences"	"chronic kidney disease"	151	173	"Diseases & Disorders"	"We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on CRP levels in chronic kidney disease (CKD) patients before and after a successful kidney transplantation."
"SA"	18708184	1	"NRG3"	51	55	"Genes & Molecular Sequences"	"schizophrenia"	65	78	"Diseases & Disorders"	"The study investigated the possible association of NRG3 gene and schizophrenia in a Han Chinese population."
"PA"	18708184	8	"rs1937970-rs677221"	83	101	"SNP & Sequence variations"	"schizophrenia"	252	265	"Diseases & Disorders"	"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed."
"PA"	18708184	5	"rs677221-C"	150	160	"SNP & Sequence variations"	"schizophrenia"	187	200	"Diseases & Disorders"	"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858)."
"PA"	18708184	5	"rs1937970"	35	44	"SNP & Sequence variations"	"schizophrenia"	187	200	"Diseases & Disorders"	"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858)."
"PA"	18708184	9	"NRG3"	29	33	"Genes & Molecular Sequences"	"schizophrenia"	68	81	"Diseases & Disorders"	"The result supports that the NRG3 gene is a susceptibility gene for schizophrenia."
"PA"	18708184	6	"Haplotypes GC"	0	13	"SNP & Sequence variations"	"schizophrenia"	81	94	"Diseases & Disorders"	"Haplotypes GC constructed by the two SNPs was also significantly associated with schizophrenia (permutation p value = .0047)."
"PA"	18708184	8	"haplotype AG"	138	150	"SNP & Sequence variations"	"schizophrenia"	252	265	"Diseases & Disorders"	"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed."
"PA"	18708184	7	"rs1937970-A"	33	44	"SNP & Sequence variations"	"schizophrenic"	114	127	"Diseases & Disorders"	"In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively)."
"PA"	18708184	7	"rs677221-G"	49	59	"SNP & Sequence variations"	"schizophrenic"	114	127	"Diseases & Disorders"	"In the independent trio samples, rs1937970-A and rs677221-G consistently showed significant under-transmission to schizophrenic offspring (unadjusted p = .003 and p = .004, respectively)."
"PA"	18708184	8	"haplotype GC"	200	212	"SNP & Sequence variations"	"schizophrenia"	252	265	"Diseases & Disorders"	"In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected schizophrenia offspring were observed."
"PA"	18708184	0	"Neuregulin 3"	0	12	"Genes & Molecular Sequences"	"schizophrenia"	54	67	"Diseases & Disorders"	"Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population."
"PA"	18708184	5	"rs677221"	49	57	"SNP & Sequence variations"	"schizophrenia"	187	200	"Diseases & Disorders"	"In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for schizophrenia (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858)."
"SA"	19098911	6	"NLRP3"	31	36	"Genes & Molecular Sequences"	"Crohn's disease"	130	145	"Diseases & Disorders"	"These results suggest that the NLRP3 region is also implicated in the susceptibility of more common inflammatory diseases such as Crohn's disease."
"PA"	19098911	1	"NLRP3"	135	140	"Genes & Molecular Sequences"	"Crohn's disease"	204	219	"Diseases & Disorders"	"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease."
"PA"	19098911	1	"NALP3"	172	177	"Genes & Molecular Sequences"	"Crohn's disease"	204	219	"Diseases & Disorders"	"We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and NALP3) that are associated with Crohn's disease."
"PA"	19098911	0	"NLRP3"	23	28	"Genes & Molecular Sequences"	"Crohn's disease"	50	65	"Diseases & Disorders"	"Common variants in the NLRP3 region contribute to Crohn's disease susceptibility."
"SA"	19115152	4	"MDR1"	32	36	"Genes & Molecular Sequences"	"inflammatory bowel disease"	93	119	"Diseases & Disorders"	"Therefore, the mutations of the MDR1 gene are thought to be related with the pathogenesis of inflammatory bowel disease."
"FA"	19115152	10	"MDR1"	57	61	"Genes & Molecular Sequences"	"Crohn's disease"	105	120	"Diseases & Disorders"	"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis."
"FA"	19115152	10	"MDR1"	57	61	"Genes & Molecular Sequences"	"ulcerative colitis"	124	142	"Diseases & Disorders"	"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis."
"NA"	19115152	10	"G2677T/A"	19	27	"SNP & Sequence variations"	"Crohn's disease"	105	120	"Diseases & Disorders"	"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis."
"NA"	19115152	10	"G2677T/A"	19	27	"SNP & Sequence variations"	"ulcerative colitis"	124	142	"Diseases & Disorders"	"In this study, the G2677T/A polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or ulcerative colitis."
"FA"	19039095	1	"hairy and enhancer of split homologue-1"	14	53	"Genes & Molecular Sequences"	"breast cancer"	134	147	"Diseases & Disorders"	"Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells."
"FA"	19039095	0	"hairy and enhancer of split homolog-1"	37	74	"Genes & Molecular Sequences"	"breast cancer"	94	107	"Diseases & Disorders"	"Estrogen-dependent downregulation of hairy and enhancer of split homolog-1 gene expression in breast cancer cells is mediated via a 3' distal element."
"PA"	19039095	1	"HES-1"	55	60	"Genes & Molecular Sequences"	"breast cancer"	134	147	"Diseases & Disorders"	"Regulation of hairy and enhancer of split homologue-1 (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human breast cancer cells."
"FA"	19107206	4	"rs13199524"	91	101	"SNP & Sequence variations"	"HIV"	189	192	"Diseases & Disorders"	"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers."
"PA"	19107206	1	"Chemokine receptor"	62	80	"Genes & Molecular Sequences"	"HIV-1 disease"	24	37	"Diseases & Disorders"	"Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load."
"PA"	19107206	5	"Syndecan 2"	275	285	"Genes & Molecular Sequences"	"HIV"	61	64	"Diseases & Disorders"	"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene)."
"FA"	19107206	4	"rs2395029"	80	89	"SNP & Sequence variations"	"HIV"	189	192	"Diseases & Disorders"	"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers."
"PA"	19107206	1	"HLA"	54	57	"Genes & Molecular Sequences"	"HIV-1 disease"	24	37	"Diseases & Disorders"	"Previous studies of the HIV-1 disease have shown that HLA and Chemokine receptor genetic variants influence disease progression and early viral load."
"FA"	19107206	5	"rs2575735"	253	262	"SNP & Sequence variations"	"HIV"	61	64	"Diseases & Disorders"	"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene)."
"FA"	19107206	4	"MHC"	69	72	"Genes & Molecular Sequences"	"HIV"	189	192	"Diseases & Disorders"	"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers."
"FA"	19107206	4	"rs3093662"	118	127	"SNP & Sequence variations"	"HIV"	189	192	"Diseases & Disorders"	"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers."
"FA"	19107206	6	"MHC"	35	38	"Genes & Molecular Sequences"	"HIV"	73	76	"Diseases & Disorders"	"Our data provide evidence that the MHC controls both HIV replication and HIV reservoir."
"FA"	19107206	4	"rs12198173"	103	113	"SNP & Sequence variations"	"HIV"	189	192	"Diseases & Disorders"	"Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term HIV controllers."
"FA"	19107206	5	"rs6503919"	168	177	"SNP & Sequence variations"	"HIV"	61	64	"Diseases & Disorders"	"Furthermore, we show that the HIV-DNA levels (reflecting the HIV reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene)."
"PA"	18508791	5	"SH3TC2"	74	80	"Genes & Molecular Sequences"	"5q- syndrome"	35	47	"Diseases & Disorders"	"The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb."
"PA"	18508791	5	"GLRA1"	105	110	"Genes & Molecular Sequences"	"5q- syndrome"	35	47	"Diseases & Disorders"	"The commonly deleted region of the 5q- syndrome extends between the genes SH3TC2 (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb."
"PA"	19106306	2	"HC gp-39"	76	84	"Genes & Molecular Sequences"	"inflammatory and allergic diseases"	121	155	"Diseases & Disorders"	"Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or HC gp-39, is involved in the pathogenesis of inflammatory and allergic diseases."
"PA"	19106306	12	"g.-247C/T"	40	49	"SNP & Sequence variations"	"atopy"	124	129	"Diseases & Disorders"	"These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy."
"PA"	19106306	0	"chitinase 3-like 1"	44	62	"Genes & Molecular Sequences"	"atopy"	82	87	"Diseases & Disorders"	"Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy."
"PA"	19106306	7	"IVS7+82C/T"	125	135	"SNP & Sequence variations"	"atopy"	233	238	"Diseases & Disorders"	"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy."
"PA"	19106306	7	"rs10399805"	93	103	"SNP & Sequence variations"	"atopy"	233	238	"Diseases & Disorders"	"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy."
"PA"	19106306	12	"CHI3L1"	70	76	"Genes & Molecular Sequences"	"atopy"	124	129	"Diseases & Disorders"	"These results strongly suggest that the g.-247C/T polymorphism in the CHI3L1 promoter region is associated with the risk of atopy."
"PA"	19106306	3	"CHI3L1"	28	34	"Genes & Molecular Sequences"	"atopic"	43	49	"Diseases & Disorders"	"The genetic contribution of CHI3L1 gene to atopic susceptibility was investigated using an integrated population genetic and molecular analysis."
"PA"	19106306	4	"CHI3L1"	22	28	"Genes & Molecular Sequences"	"atopy"	90	95	"Diseases & Disorders"	"Genetic variations in CHI3L1 were identified and genotyped in 295 unrelated patients with atopy and 180 control subjects."
"PA"	19106306	7	"CHI3L1"	188	194	"Genes & Molecular Sequences"	"atopy"	233	238	"Diseases & Disorders"	"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy."
"PA"	19106306	7	"rs2275353"	162	171	"SNP & Sequence variations"	"atopy"	233	238	"Diseases & Disorders"	"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy."
"PA"	19106306	7	"g.-247C/T"	46	55	"SNP & Sequence variations"	"atopy"	233	238	"Diseases & Disorders"	"In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with atopy."
"FA"	17898177	4	"CEP290/NPHP6"	61	73	"Genes & Molecular Sequences"	"Leber congenital amaurosis"	163	189	"Diseases & Disorders"	"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy."
"FA"	17898177	0	"CEP290"	12	18	"Genes & Molecular Sequences"	"anosmia"	45	52	"Diseases & Disorders"	"Hypomorphic CEP290/NPHP6 mutations result in anosmia caused by the selective loss of G proteins in cilia of olfactory sensory neurons."
"PA"	17898177	4	"CEP290/NPHP6"	61	73	"Genes & Molecular Sequences"	"Meckel syndromes"	105	121	"Diseases & Disorders"	"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy."
"PA"	17898177	4	"CEP290/NPHP6"	61	73	"Genes & Molecular Sequences"	"Joubert"	93	100	"Diseases & Disorders"	"In humans, loss-of-function of the cilia-centrosomal protein CEP290/NPHP6 is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy."
"SA"	19104434	0	"MBL promoter haplotype"	26	48	"Genes & Molecular Sequences"	"BOS"	91	94	"Diseases & Disorders"	"Association between donor MBL promoter haplotype and graft survival and the development of BOS after lung transplantation."
"NA"	18297189	9	"epsilon4"	69	77	"SNP & Sequence variations"	"hypertension"	113	125	"Diseases & Disorders"	"Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively)."
"NA"	18297189	9	"epsilon2"	52	60	"SNP & Sequence variations"	"hypertension"	113	125	"Diseases & Disorders"	"Compared with the epsilon3 homozygotes, neither the epsilon2 nor the epsilon4 carrier status was associated with hypertension (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively)."
"PA"	18297189	1	"Apolipoprotein E"	0	16	"Genes & Molecular Sequences"	"arterial hypertension"	91	112	"Diseases & Disorders"	"Apolipoprotein E (ApoE) polymorphism influences lipid metabolism, but its association with arterial hypertension is controversial."
"NA"	18297189	11	"ApoE"	52	56	"Genes & Molecular Sequences"	"prevalent hypertension"	89	111	"Diseases & Disorders"	"This study provides epidemiologic evidence that the ApoE genotype is not associated with prevalent hypertension in old age."
"PA"	19099048	4	"MMP"	180	183	"Genes & Molecular Sequences"	"TAA"	673	676	"Diseases & Disorders"	"Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease."
"PA"	19099048	4	"matrix metalloproteinase"	154	178	"Genes & Molecular Sequences"	"TAA"	673	676	"Diseases & Disorders"	"Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to TAA and can serve as biomarkers for screening for this virulent disease."
"FA"	19092295	4	"LIGIV"	282	287	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"PRO72ARG"	555	563	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	0	"RAD52 polymorphisms"	0	19	"Genes & Molecular Sequences"	"papillary thyroid cancer"	53	77	"Diseases & Disorders"	"RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population."
"PA"	19092295	4	"Tp53"	565	569	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"ARG280HIS"	632	641	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"GLN221GLU"	494	503	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	4	"XRCC1"	615	620	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"SA"	19092295	8	"RAD52 GLN221GLU"	40	55	"SNP & Sequence variations"	"papillary thyroid cancer"	123	147	"Diseases & Disorders"	"Of the 21 loci screened, RAD52 2259 and RAD52 GLN221GLU may be of importance to disease process and may be associated with papillary thyroid cancer risk in Saudi Arabian population."
"FA"	19092295	4	"THR241MET"	432	441	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"PRO231SER"	305	314	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"ARG399GLN"	643	652	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	4	"XRCC7"	356	361	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"ARG559GLN"	654	663	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"15455419A>G"	466	477	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	5	"RAD52 GLN221GLU"	0	15	"SNP & Sequence variations"	"thyroid cancer"	125	139	"Diseases & Disorders"	"RAD52 GLN221GLU genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing thyroid cancer compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58]."
"PA"	19092295	4	"RAD51"	443	448	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	4	"XRCC3"	413	418	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"TRP46TER"	316	324	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"FA"	19092295	4	"LIGlV ASP62HIS"	289	303	"SNP & Sequence variations"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	19092295	4	"XRCC4"	327	332	"Genes & Molecular Sequences"	"papillary thyroid cancer"	38	62	"Diseases & Disorders"	"Two hundred and twenty-three incident papillary thyroid cancer cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN."
"PA"	18479189	2	"GPx1"	127	131	"Genes & Molecular Sequences"	"colitis"	94	101	"Diseases & Disorders"	"An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice."
"PA"	18479189	2	"GPx1"	127	131	"Genes & Molecular Sequences"	"intestinal cancer"	106	123	"Diseases & Disorders"	"An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice."
"SA"	18479189	11	"GPx2"	6	10	"Genes & Molecular Sequences"	"carcinogenesis"	118	132	"Diseases & Disorders"	"Thus, GPx2 may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of carcinogenesis."
"PA"	18479189	4	"COX-2"	22	27	"Genes & Molecular Sequences"	"inflammation"	71	83	"Diseases & Disorders"	"In contrast, enhanced COX-2 expression is consistently associated with inflammation."
"PA"	18479189	2	"GPx2"	136	140	"Genes & Molecular Sequences"	"intestinal cancer"	106	123	"Diseases & Disorders"	"An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice."
"PA"	18479189	2	"GPx2"	136	140	"Genes & Molecular Sequences"	"colitis"	94	101	"Diseases & Disorders"	"An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and intestinal cancer in GPx1 and GPx2 double knockout mice."
"FA"	18804983	10	"CARD15"	96	102	"Genes & Molecular Sequences"	"CD"	164	166	"Diseases & Disorders"	"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A."
"PA"	18804983	10	"G908R"	123	128	"SNP & Sequence variations"	"CD"	164	166	"Diseases & Disorders"	"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A."
"PA"	18804983	10	"L1007fsinsC"	133	144	"SNP & Sequence variations"	"CD"	164	166	"Diseases & Disorders"	"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A."
"PA"	18804983	10	"TNF-alpha-G308A"	207	222	"SNP & Sequence variations"	"CD"	164	166	"Diseases & Disorders"	"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A."
"NA"	18804983	9	"NF kappaB -94ATTG"	4	21	"SNP & Sequence variations"	"CD"	62	64	"Diseases & Disorders"	"The NF kappaB -94ATTG variants was found to be irrelevant for CD."
"PA"	18804983	10	"FcGIIIA G559T"	189	202	"SNP & Sequence variations"	"CD"	164	166	"Diseases & Disorders"	"For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with CD to the same extent as FcGIIIA G559T and TNF-alpha-G308A."
"PA"	19111066	3	"C-allele of PKLR rs3020781"	4	30	"SNP & Sequence variations"	"type 2 diabetes"	108	123	"Diseases & Disorders"	"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively."
"NA"	19111066	11	"PKLR"	18	22	"Genes & Molecular Sequences"	"diabetes-related quantitative metabolic phenotypes"	99	149	"Diseases & Disorders"	"Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes."
"FA"	19111066	12	"NOS1AP rs7538490"	75	91	"Genes & Molecular Sequences"	"overweight"	113	123	"Diseases & Disorders"	"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes."
"PA"	19111066	3	"PKLR"	16	20	"Genes & Molecular Sequences"	"type 2 diabetes"	108	123	"Diseases & Disorders"	"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively."
"NA"	19111066	12	"PKLR rs3020781"	56	70	"Genes & Molecular Sequences"	"type 2 diabetes"	96	111	"Diseases & Disorders"	"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes."
"NA"	19111066	9	"rs3020781"	63	72	"SNP & Sequence variations"	"type 2 diabetes"	46	61	"Diseases & Disorders"	"No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06])."
"FA"	19111066	0	"NOS1AP rs7538490"	47	63	"Genes & Molecular Sequences"	"obesity"	97	104	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"FA"	19111066	0	"NOS1AP rs7538490"	47	63	"Genes & Molecular Sequences"	"overweight"	85	95	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"FA"	19111066	12	"NOS1AP rs7538490"	75	91	"Genes & Molecular Sequences"	"obesity"	125	132	"Diseases & Disorders"	"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes."
"NA"	19111066	0	"PKLR rs3020781"	28	42	"Genes & Molecular Sequences"	"type 2 diabetes"	68	83	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"PA"	19111066	3	"T-allele of NOS1AP rs7538490"	39	67	"SNP & Sequence variations"	"type 2 diabetes"	108	123	"Diseases & Disorders"	"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively."
"NA"	19111066	0	"NOS1AP rs7538490"	47	63	"Genes & Molecular Sequences"	"type 2 diabetes"	68	83	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"NA"	19111066	12	"NOS1AP rs7538490"	75	91	"Genes & Molecular Sequences"	"type 2 diabetes"	96	111	"Diseases & Disorders"	"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes."
"NA"	19111066	11	"NOS1AP"	31	37	"Genes & Molecular Sequences"	"diabetes-related quantitative metabolic phenotypes"	99	149	"Diseases & Disorders"	"Additionally, the PKLR and the NOS1AP genotypes were demonstrated not to have a major influence on diabetes-related quantitative metabolic phenotypes."
"NA"	19111066	9	"rs7538490"	109	118	"SNP & Sequence variations"	"type 2 diabetes"	46	61	"Diseases & Disorders"	"No significant associations were observed for type 2 diabetes (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06])."
"PA"	19111066	3	"NOS1AP"	51	57	"Genes & Molecular Sequences"	"type 2 diabetes"	108	123	"Diseases & Disorders"	"The C-allele of PKLR rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with type 2 diabetes in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively."
"FA"	19111066	12	"PKLR rs3020781"	56	70	"Genes & Molecular Sequences"	"obesity"	125	132	"Diseases & Disorders"	"We failed to provide evidence of an association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes."
"FA"	19111066	0	"PKLR rs3020781"	28	42	"Genes & Molecular Sequences"	"overweight"	85	95	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"FA"	19111066	0	"PKLR rs3020781"	28	42	"Genes & Molecular Sequences"	"obesity"	97	104	"Diseases & Disorders"	"Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits."
"PA"	18202791	2	"COX-2"	214	219	"Genes & Molecular Sequences"	"oral leukoplakia"	105	121	"Diseases & Disorders"	"Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam)."
"PA"	18202791	2	"COX-2"	214	219	"Genes & Molecular Sequences"	"squamous cell carcinoma"	126	149	"Diseases & Disorders"	"Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and squamous cell carcinoma, relatively little research has compared the effects of various COX-2 inhibitors (celecoxib, NS-398, nimesulide and meloxicam)."
"FA"	18202791	8	"COX-2"	158	163	"Genes & Molecular Sequences"	"OSCC"	71	75	"Diseases & Disorders"	"Taken together, celecoxib is a good therapeutic candidate for treating OSCC through the suppression of cell proliferation and the induction of apoptosis in a COX-2 independent manner."
"PA"	19114657	0	"STK39"	58	63	"Genes & Molecular Sequences"	"hypertension"	69	81	"Diseases & Disorders"	"From the Cover: Whole-genome association study identifies STK39 as a hypertension susceptibility gene."
"PA"	17618837	1	"rs11209026"	84	94	"SNP & Sequence variations"	"CD"	166	168	"Diseases & Disorders"	"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults."
"PA"	17618837	1	"IL23R"	132	137	"Genes & Molecular Sequences"	"Crohn's disease"	149	164	"Diseases & Disorders"	"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults."
"FA"	17618837	1	"IL23R"	132	137	"Genes & Molecular Sequences"	"CD"	166	168	"Diseases & Disorders"	"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults."
"PA"	17618837	1	"rs11209026"	84	94	"SNP & Sequence variations"	"Crohn's disease"	149	164	"Diseases & Disorders"	"Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (CD) as a consequence of a genome-wide association study of this disease in adults."
"FA"	17618837	3	"IL23R"	201	206	"Genes & Molecular Sequences"	"CD"	92	94	"Diseases & Disorders"	"By using data from our ongoing genome-wide association study in our cohort of 142 pediatric CD patients and 281 matched controls, we investigated the association of the previously reported SNPs at the IL23R locus with the childhood form of this disease."
"PA"	17618837	9	"variants in the IL23R"	9	30	"Genes & Molecular Sequences"	"CD"	74	76	"Diseases & Disorders"	"As such, variants in the IL23R gene confer a similar magnitude of risk of CD to children as for their adult counterparts."
"PA"	17618837	8	"IL23R variant"	14	27	"Genes & Molecular Sequences"	"inflammatory bowel disease"	124	150	"Diseases & Disorders"	"The OR of the IL23R variant in our pediatric study is highly comparable with that reported previously in a non-Jewish adult inflammatory bowel disease case-control cohort (OR, 0.26)."
"PA"	17618837	0	"interleukin-23 receptor"	31	54	"Genes & Molecular Sequences"	"pediatric Crohn's disease"	83	108	"Diseases & Disorders"	"Association of variants of the interleukin-23 receptor gene with susceptibility to pediatric Crohn's disease."
"PA"	19104506	0	"interleukin-1 receptor antagonist"	18	51	"Genes & Molecular Sequences"	"colorectal cancer"	102	119	"Diseases & Disorders"	"Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer."
"SA"	19104506	1	"IL-1RA"	39	45	"Genes & Molecular Sequences"	"metastasis"	100	110	"Diseases & Disorders"	"The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis."
"SA"	19104506	1	"IL-1RA"	39	45	"Genes & Molecular Sequences"	"tumor angiogenesis"	81	99	"Diseases & Disorders"	"The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis."
"FA"	19104506	3	"rs579543 T/T"	162	174	"SNP & Sequence variations"	"metastatic colorectal cancer"	29	57	"Diseases & Disorders"	"A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers)."
"PA"	19104506	3	"IL-1RA"	83	89	"Genes & Molecular Sequences"	"metastatic colorectal cancer"	29	57	"Diseases & Disorders"	"A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers)."
"FA"	19104506	3	"rs4251961 T/T"	145	158	"SNP & Sequence variations"	"metastatic colorectal cancer"	29	57	"Diseases & Disorders"	"A total of 180 patients with metastatic colorectal cancer were categorized as high IL-1RA producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers)."
"SA"	19105801	2	"VDR"	20	23	"Genes & Molecular Sequences"	"MM"	152	154	"Diseases & Disorders"	"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population."
"SA"	19105801	2	"VDR"	20	23	"Genes & Molecular Sequences"	"sporadic breast cancer"	101	123	"Diseases & Disorders"	"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population."
"SA"	19105801	2	"VDR"	20	23	"Genes & Molecular Sequences"	"malignant melanoma"	132	150	"Diseases & Disorders"	"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population."
"SA"	19105801	7	"rs731236"	23	31	"SNP & Sequence variations"	"BC"	86	88	"Diseases & Disorders"	"The synonymous variant rs731236 (TaqI) appeared to be associated with protection from BC (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047)."
"SA"	19105801	2	"VDR"	20	23	"Genes & Molecular Sequences"	"BC"	125	127	"Diseases & Disorders"	"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population."
"PA"	19105801	2	"VDR"	20	23	"Genes & Molecular Sequences"	"cancer"	49	55	"Diseases & Disorders"	"Vitamin D receptor (VDR) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population."
"SA"	19105801	10	"SNPs in the VDR"	45	60	"Genes & Molecular Sequences"	"MM"	212	214	"Diseases & Disorders"	"In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM."
"FA"	19105801	6	"rs2228570"	65	74	"SNP & Sequence variations"	"BC"	120	122	"Diseases & Disorders"	"An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036)."
"PA"	19105801	6	"rs10735810"	76	86	"SNP & Sequence variations"	"BC"	120	122	"Diseases & Disorders"	"An association with the minor allele A of the non-synonymous SNP rs2228570 (rs10735810, FokI, Met1Thr) was observed for BC, with an estimated odds ratio (OR) of 1.26 (95% CI = 1.02-1.57; p = 0.036)."
"PA"	19105801	10	"SNPs in the VDR"	45	60	"Genes & Molecular Sequences"	"BC"	70	72	"Diseases & Disorders"	"In summary, we observed associations between SNPs in the VDR gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with MM."
"PA"	19105843	1	"INSIG2"	29	35	"Genes & Molecular Sequences"	"obesity"	136	143	"Diseases & Disorders"	"A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts."
"FA"	19105843	1	"rs7566605"	42	51	"SNP & Sequence variations"	"obesity"	136	143	"Diseases & Disorders"	"A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C, Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index, [BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been reproduced in other cohorts."
"PA"	19105843	10	"INSIG2 rs7566605"	108	124	"Genes & Molecular Sequences"	"obesity"	96	103	"Diseases & Disorders"	"This supports and extends the original finding that there is an association between measures of obesity and INSIG2 rs7566605 and further implicates this polymorphism in fat regulation."
"PA"	19105843	9	"INSIG2 rs7566605"	26	42	"Genes & Molecular Sequences"	"adiposity"	92	101	"Diseases & Disorders"	"Our results show that the INSIG2 rs7566605 polymorphism underlies variation in subcutaneous adiposity in young adult women and suppresses the positive effects of resistance training on men."
"PA"	19101508	2	"HCNPpp"	51	57	"Genes & Molecular Sequences"	"AD"	213	215	"Diseases & Disorders"	"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD."
"PA"	19101508	2	"HCNPpp"	51	57	"Genes & Molecular Sequences"	"Alzheimer's disease"	118	137	"Diseases & Disorders"	"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD."
"FA"	19101508	3	"HCNPpp"	90	96	"Genes & Molecular Sequences"	"AD"	200	202	"Diseases & Disorders"	"To clarify the involvement of gene variations in the promoter region of the gene encoding HCNPpp in this mRNA reduction, we analyzed DNA polymorphisms or mutations within this gene promoter region in AD patients by direct sequencing."
"PA"	19101508	2	"HCNP"	183	187	"Genes & Molecular Sequences"	"AD"	213	215	"Diseases & Disorders"	"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD."
"PA"	19101508	2	"HCNP"	183	187	"Genes & Molecular Sequences"	"Alzheimer's disease"	118	137	"Diseases & Disorders"	"Our previous study demonstrated that expression of HCNPpp mRNA was decreased in the hippocampi of autopsied brains of Alzheimer's disease (AD) patients, indicating the association of HCNP with the pathogenesis of AD."
"PA"	19107338	2	"K121Q"	4	9	"SNP & Sequence variations"	"insulin resistance"	194	212	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"PA"	19107338	2	"K121Q"	4	9	"SNP & Sequence variations"	"obesity"	217	224	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"FA"	19107338	0	"ectonucleotide pyrophosphatase/phosphodiesterase 1"	41	91	"Genes & Molecular Sequences"	"hepatitis C virus infection"	97	124	"Diseases & Disorders"	"Association of a genetic polymorphism in ectonucleotide pyrophosphatase/phosphodiesterase 1 with hepatitis C virus infection and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan."
"FA"	19107338	8	"rs7566605"	17	26	"SNP & Sequence variations"	"hepatitis C"	60	71	"Diseases & Disorders"	"In contrast, the rs7566605 genotype was not associated with hepatitis C viremia or with the HCV core antigen level."
"FA"	19107338	9	"K121Q"	4	9	"SNP & Sequence variations"	"hepatitis C"	50	61	"Diseases & Disorders"	"The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers."
"FA"	19107338	2	"ENPP)-1"	80	87	"Genes & Molecular Sequences"	"obesity"	217	224	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"FA"	19107338	2	"ENPP)-1"	80	87	"Genes & Molecular Sequences"	"insulin resistance"	194	212	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"PA"	19107338	3	"K121Q"	32	37	"SNP & Sequence variations"	"HCV infection"	128	141	"Diseases & Disorders"	"This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection."
"PA"	19107338	3	"rs7566605"	67	76	"SNP & Sequence variations"	"HCV infection"	128	141	"Diseases & Disorders"	"This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection."
"PA"	19107338	3	"ENPP1"	54	59	"Genes & Molecular Sequences"	"HCV infection"	128	141	"Diseases & Disorders"	"This study examined whether the K121Q polymorphism in ENPP1 or the rs7566605 genotype is associated with the clinical course of HCV infection."
"PA"	19107338	2	"rs7566605"	101	110	"SNP & Sequence variations"	"insulin resistance"	194	212	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"PA"	19107338	9	"ENPP1"	21	26	"Genes & Molecular Sequences"	"hepatitis C"	50	61	"Diseases & Disorders"	"The K121Q variant of ENPP1 may be associated with hepatitis C viremia and core antigen levels in HCV carriers."
"PA"	19107338	2	"rs7566605"	101	110	"SNP & Sequence variations"	"obesity"	217	224	"Diseases & Disorders"	"The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (ENPP)-1 gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and obesity."
"PA"	19110537	6	"IL-10"	175	180	"Genes & Molecular Sequences"	"Mycobacterium leprae antigens"	90	119	"Diseases & Disorders"	"Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers."
"SA"	19110537	7	"IL-10"	54	59	"Genes & Molecular Sequences"	"leprosy"	166	173	"Diseases & Disorders"	"Taken together, these data suggest that low levels of IL-10 during the disease outcome can drive patients to a chronic and unprotective response that culminates with leprosy."
"PA"	19110537	0	"interleukin-10 promoter single-nucleotide polymorphisms"	52	107	"Genes & Molecular Sequences"	"leprosy"	150	157	"Diseases & Disorders"	"Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility."
"PA"	19110537	3	"IL-10"	221	226	"Genes & Molecular Sequences"	"leprosy"	247	254	"Diseases & Disorders"	"Here, we combined a case-control study (374 patients and 380 controls), with meta-analysis (5 studies; 2702 individuals) and biological study to test the epidemiological and physiological relevance of the interleukin-10 (IL-10) genetic markers in leprosy."
"PA"	19110537	0	"-819C/T"	139	146	"SNP & Sequence variations"	"leprosy"	150	157	"Diseases & Disorders"	"Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility."
"PA"	19110537	5	"-819T"	103	108	"SNP & Sequence variations"	"leprosy"	119	126	"Diseases & Disorders"	"Haplotypes combining promoter single-nucleotide polymorphisms also implicated a haplotype carrying the -819T allele in leprosy susceptibility (odds ratio (OR)=1.40; P=0.01)."
"FA"	19110537	6	"-819T"	135	140	"SNP & Sequence variations"	"Mycobacterium leprae antigens"	90	119	"Diseases & Disorders"	"Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with Mycobacterium leprae antigens and found that -819T carriers produced lower levels of IL-10 when compared with non-carriers."
"PA"	19110537	4	"-819T"	21	26	"SNP & Sequence variations"	"leprosy"	53	60	"Diseases & Disorders"	"We observed that the -819T allele is associated with leprosy susceptibility either in the case-control or in the meta-analysis studies."
"FA"	19098994	2	"LOXL1 polymorphisms"	15	34	"Genes & Molecular Sequences"	"POAG"	94	98	"Diseases & Disorders"	"The implicated LOXL1 polymorphisms have not been associated with primary open-angle glaucoma (POAG)."
"NA"	19098994	12	"rs3825942"	34	43	"SNP & Sequence variations"	"POAG"	85	89	"Diseases & Disorders"	"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population."
"PA"	19098994	1	"LOXL1"	34	39	"Genes & Molecular Sequences"	"exfoliation glaucoma"	74	94	"Diseases & Disorders"	"The lysyl oxidase-like protein 1 (LOXL1) gene is strongly associated with exfoliation glaucoma, which is very rare in the Chinese population."
"SA"	19098994	14	"rs1048661"	46	55	"SNP & Sequence variations"	"exfoliation syndrome"	130	150	"Diseases & Disorders"	"The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese."
"NA"	19098994	12	"rs2165241"	49	58	"SNP & Sequence variations"	"POAG"	85	89	"Diseases & Disorders"	"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population."
"SA"	19098994	14	"rs2165241"	60	69	"SNP & Sequence variations"	"exfoliation syndrome"	130	150	"Diseases & Disorders"	"The low frequencies of the at-risk alleles at rs1048661 and rs2165241 may be one of the factors that led to the low prevalence of exfoliation syndrome in the general populations of the Chinese."
"FA"	19098994	12	"LOXL1"	11	16	"Genes & Molecular Sequences"	"POAG"	85	89	"Diseases & Disorders"	"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population."
"NA"	19098994	12	"rs1048661"	23	32	"SNP & Sequence variations"	"POAG"	85	89	"Diseases & Disorders"	"Individual LOXL1 SNPs, rs1048661, rs3825942, and rs2165241, were not associated with POAG in the Chinese population."
"PA"	19366086	0	"A1298C mutations of the MTHFR"	42	71	"Genes & Molecular Sequences"	"hyperhomocysteinemia"	90	110	"Diseases & Disorders"	"Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age."
"FA"	19366086	0	"C677T"	32	37	"SNP & Sequence variations"	"hyperhomocysteinemia"	90	110	"Diseases & Disorders"	"Compound heterozygosity for the C677T and A1298C mutations of the MTHFR gene in a case of hyperhomocysteinemia with recurrent deep thrombosis at young age."
"FA"	19094116	7	"NOD2"	66	70	"Genes & Molecular Sequences"	"CD"	3	5	"Diseases & Disorders"	"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms."
"FA"	19094116	12	"GM-CSF"	150	156	"Genes & Molecular Sequences"	"CD"	95	97	"Diseases & Disorders"	"The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor."
"FA"	19094116	4	"NOD2 SNP"	9	17	"Genes & Molecular Sequences"	"CD"	31	33	"Diseases & Disorders"	"Based on NOD2 SNP analyses, 41 CD patients and 12 healthy controls were studied."
"PA"	19094116	0	"Toll-like receptor"	0	18	"Genes & Molecular Sequences"	"Crohn's disease"	101	116	"Diseases & Disorders"	"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways."
"PA"	19094116	0	"granulocyte-macrophage colony-stimulating factor"	27	75	"Genes & Molecular Sequences"	"Crohn's disease"	101	116	"Diseases & Disorders"	"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways."
"FA"	19094116	8	"TLR"	48	51	"Genes & Molecular Sequences"	"CD"	162	164	"Diseases & Disorders"	"Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients."
"FA"	19094116	11	"GM-CSF"	26	32	"Genes & Molecular Sequences"	"CD"	0	2	"Diseases & Disorders"	"CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion."
"FA"	19094116	11	"TNF-alpha"	146	155	"Genes & Molecular Sequences"	"CD"	0	2	"Diseases & Disorders"	"CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion."
"PA"	19094116	2	"NOD2"	151	155	"Genes & Molecular Sequences"	"Crohn's disease"	214	229	"Diseases & Disorders"	"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD)."
"PA"	19094116	2	"NOD2"	151	155	"Genes & Molecular Sequences"	"CD"	231	233	"Diseases & Disorders"	"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD)."
"FA"	19094116	10	"GM-CSF"	72	78	"Genes & Molecular Sequences"	"CD"	0	2	"Diseases & Disorders"	"CD patients with NOD2 mutations were able to secrete TNF-alpha, but not GM-CSF, upon stimulation with NOD2 and TLR-7 ligands."
"PA"	19094116	12	"NOD2"	189	193	"Genes & Molecular Sequences"	"CD"	95	97	"Diseases & Disorders"	"The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of CD and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a NOD2-dependent disease risk factor."
"PA"	19094116	11	"NOD2"	112	116	"Genes & Molecular Sequences"	"CD"	0	2	"Diseases & Disorders"	"CD patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion."
"PA"	19094116	2	"nucleotide oligomerization domain 2"	157	192	"Genes & Molecular Sequences"	"CD"	231	233	"Diseases & Disorders"	"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD)."
"PA"	19094116	2	"nucleotide oligomerization domain 2"	157	192	"Genes & Molecular Sequences"	"Crohn's disease"	214	229	"Diseases & Disorders"	"Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, nucleotide oligomerization domain 2) are associated with Crohn's disease (CD)."
"FA"	19094116	7	"GM-CSF"	28	34	"Genes & Molecular Sequences"	"CD"	3	5	"Diseases & Disorders"	"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms."
"FA"	19094116	0	"nucleotide oligomerization domain 2"	120	155	"Genes & Molecular Sequences"	"Crohn's disease"	101	116	"Diseases & Disorders"	"Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways."
"PA"	19094116	8	"NOD2"	100	104	"Genes & Molecular Sequences"	"CD"	162	164	"Diseases & Disorders"	"Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in CD patients."
"PA"	19094116	7	"TLR"	16	19	"Genes & Molecular Sequences"	"CD"	3	5	"Diseases & Disorders"	"In CD patients, TLR-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms."
"PA"	18470928	1	"IL-23"	4	9	"Genes & Molecular Sequences"	"chronic mucosal inflammation"	61	89	"Diseases & Disorders"	"The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases."
"SA"	18470928	0	"IL23R haplotypes"	0	16	"Genes & Molecular Sequences"	"Crohn's disease"	66	81	"Diseases & Disorders"	"IL23R haplotypes provide a large population attributable risk for Crohn's disease."
"PA"	18470928	2	"IL23R R381Q"	150	161	"SNP & Sequence variations"	"Crohn's disease"	102	117	"Diseases & Disorders"	"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular."
"SA"	18470928	8	"R381Q"	157	162	"SNP & Sequence variations"	"CD"	74	76	"Diseases & Disorders"	"These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant."
"PA"	18470928	2	"IL23R R381Q"	150	161	"SNP & Sequence variations"	"CD"	119	121	"Diseases & Disorders"	"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular."
"PA"	18470928	1	"IL-23"	4	9	"Genes & Molecular Sequences"	"inflammatory bowel diseases"	102	129	"Diseases & Disorders"	"The IL-23 pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the inflammatory bowel diseases."
"PA"	18470928	2	"IL23R"	92	97	"Genes & Molecular Sequences"	"CD"	119	121	"Diseases & Disorders"	"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular."
"SA"	18470928	8	"IL23R"	32	37	"Genes & Molecular Sequences"	"CD"	74	76	"Diseases & Disorders"	"These observations suggest that IL23R makes a substantial contribution to CD susceptibility, larger than that estimated from the population frequency of the R381Q variant."
"PA"	18470928	2	"IL23R"	92	97	"Genes & Molecular Sequences"	"Crohn's disease"	102	117	"Diseases & Disorders"	"Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (CD) risk in general and of the IL23R R381Q variant in particular."
"FA"	18470928	4	"IL23R"	99	104	"Genes & Molecular Sequences"	"CD"	12	14	"Diseases & Disorders"	"In all, 763 CD subjects and 254 controls were genotyped for single nucleotide polymorphisms in the IL23R gene using Illumina and ABI methods."
"PA"	18846214	0	"3q26"	99	103	"Genes & Molecular Sequences"	"myopia"	46	52	"Diseases & Disorders"	"Identification and replication of three novel myopia common susceptibility gene loci on chromosome 3q26 using linkage and linkage disequilibrium mapping."
"PA"	17592645	15	"c.+119A > T in the 3'-UTR"	25	50	"SNP & Sequence variations"	"ASD type II"	67	78	"Diseases & Disorders"	"In a family, we observed c.+119A > T in the 3'-UTR associated with ASD type II."
"PA"	19029774	0	"growth hormone-releasing hormone receptor messenger ribonucleic acid"	13	81	"Genes & Molecular Sequences"	"growth hormone-secreting pituitary adenoma"	96	138	"Diseases & Disorders"	"Elevation of growth hormone-releasing hormone receptor messenger ribonucleic acid expression in growth hormone-secreting pituitary adenoma with Gsalpha protein mutation."
"PA"	19029774	2	"GHRH receptor"	18	31	"Genes & Molecular Sequences"	"GH-secreting pituitary adenoma"	111	141	"Diseases & Disorders"	"The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells."
"PA"	19029774	10	"GHRH"	257	261	"Genes & Molecular Sequences"	"GH-secreting pituitary adenoma"	78	108	"Diseases & Disorders"	"These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling."
"PA"	19029774	2	"GHRH"	56	60	"Genes & Molecular Sequences"	"GH-secreting pituitary adenoma"	111	141	"Diseases & Disorders"	"The expression of GHRH receptor (GHRHR) is regulated by GHRH, both of which are known to be expressed in human GH-secreting pituitary adenoma cells."
"PA"	19029774	10	"GHRHR mRNA"	195	205	"Genes & Molecular Sequences"	"GH-secreting pituitary adenoma"	78	108	"Diseases & Disorders"	"These results suggest that gsp mutations up-regulate GHRHR mRNA expression in GH-secreting pituitary adenoma cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of GHRH signaling."
"PA"	19101572	1	"Cdc6"	0	4	"Genes & Molecular Sequences"	"carcinogenesis"	47	61	"Diseases & Disorders"	"Cdc6 play crucial roles in DNA replication and carcinogenesis."
"PA"	19101572	8	"Cdc6 G1321A"	45	56	"Genes & Molecular Sequences"	"cancer"	107	113	"Diseases & Disorders"	"Our data provide the first evidence that the Cdc6 G1321A polymorphism is associated with decreased risk of cancer."
"PA"	18630531	4	"VEGF"	91	95	"Genes & Molecular Sequences"	"breast cancer"	36	49	"Diseases & Disorders"	"To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry."
"PA"	18630531	4	"VEGFR-1"	100	107	"Genes & Molecular Sequences"	"breast cancer"	36	49	"Diseases & Disorders"	"To assess clinical significance, 93 breast cancer lesions were evaluated for expression of VEGF and VEGFR-1 by immunohistochemistry."
"PA"	18630531	0	"Flt-1"	23	28	"Genes & Molecular Sequences"	"breast cancer"	33	46	"Diseases & Disorders"	"Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage."
"PA"	18630531	0	"VEGF"	66	70	"Genes & Molecular Sequences"	"breast cancer"	33	46	"Diseases & Disorders"	"Expression of VEGFR-1 (Flt-1) in breast cancer is associated with VEGF expression and with node-negative tumour stage."
"PA"	18630531	6	"VEGF"	0	4	"Genes & Molecular Sequences"	"breast cancer"	48	61	"Diseases & Disorders"	"VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens."
"PA"	18630531	6	"VEGFR-1"	30	37	"Genes & Molecular Sequences"	"breast cancer"	48	61	"Diseases & Disorders"	"VEGF was expressed in 60% and VEGFR-1 in 39% of breast cancer specimens."
"PA"	18630531	1	"VEGF"	36	40	"Genes & Molecular Sequences"	"breast cancer"	51	64	"Diseases & Disorders"	"Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells."
"PA"	18630531	1	"Flt-1"	203	208	"Genes & Molecular Sequences"	"breast cancer"	51	64	"Diseases & Disorders"	"Vascular endothelial growth factor (VEGF) promotes breast cancer progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells."
"FA"	19106270	3	"rs11594656"	92	102	"SNP & Sequence variations"	"type 1 diabetes"	138	153	"Diseases & Disorders"	"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin."
"PA"	19106270	2	"IL2RA"	55	60	"Genes & Molecular Sequences"	"type 1 diabetes"	86	101	"Diseases & Disorders"	"Our objective was to determine whether variants in the IL2RA gene are associated with type 1 diabetes in the Japanese population."
"PA"	19106270	3	"IL2RA"	111	116	"Genes & Molecular Sequences"	"type 1 diabetes"	138	153	"Diseases & Disorders"	"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin."
"PA"	19106270	8	"IL2RA"	129	134	"Genes & Molecular Sequences"	"type 1 diabetes"	191	206	"Diseases & Disorders"	"The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the IL2RA in the susceptibility to acute-onset and other forms of type 1 diabetes in the Japanese population."
"FA"	19106270	3	"rs3118470"	65	74	"SNP & Sequence variations"	"type 1 diabetes"	138	153	"Diseases & Disorders"	"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin."
"FA"	19106270	3	"rs706778"	55	63	"SNP & Sequence variations"	"type 1 diabetes"	138	153	"Diseases & Disorders"	"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin."
"PA"	19106270	5	"rs3118470"	177	186	"SNP & Sequence variations"	"type 1 diabetes"	85	100	"Diseases & Disorders"	"We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470)."
"PA"	19106270	5	"rs706778"	164	172	"SNP & Sequence variations"	"type 1 diabetes"	85	100	"Diseases & Disorders"	"We found evidence of association with acute-onset, but not slow-onset and fulminant, type 1 diabetes for two of the four single-nucleotide polymorphisms genotyped (rs706778 and rs3118470)."
"FA"	19106270	3	"ss52580101"	76	86	"SNP & Sequence variations"	"type 1 diabetes"	138	153	"Diseases & Disorders"	"We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with type 1 diabetes and 606 control subjects of Japanese origin."
"PA"	17659994	1	"TGFBIp/betaig-h3"	0	16	"Genes & Molecular Sequences"	"adenocarcinoma"	89	103	"Diseases & Disorders"	"TGFBIp/betaig-h3 protein is an extracellular matrix molecule initially cloned from human adenocarcinoma cells treated with TGF-beta."
"PA"	19092998	0	"Cyclophilin A"	46	59	"Genes & Molecular Sequences"	"infection"	104	113	"Diseases & Disorders"	"Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection."
"PA"	19092998	1	"Cyclophilin A"	101	114	"Genes & Molecular Sequences"	"infection"	155	164	"Diseases & Disorders"	"Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression."
"PA"	19092998	1	"CypA"	116	120	"Genes & Molecular Sequences"	"infection"	155	164	"Diseases & Disorders"	"Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (CypA) and susceptibility to both HIV-1 infection and disease progression."
"FA"	19092998	7	"CypA"	104	108	"Genes & Molecular Sequences"	"infection"	159	168	"Diseases & Disorders"	"The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the CypA gene may be associated with protection from HIV-1 infection, while the 1604G allele may have a weak association with the clinical course of infection in DU."
"FA"	19096231	6	"His1104Asp"	142	152	"SNP & Sequence variations"	"cervical squamous cell carcinoma"	97	129	"Diseases & Disorders"	"Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes."
"NA"	19096231	8	"XPD Lys751Gln"	37	50	"SNP & Sequence variations"	"cervical carcinoma"	55	73	"Diseases & Disorders"	"No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found."
"PA"	19096231	2	"XRCC3"	48	53	"Genes & Molecular Sequences"	"carcinogenesis"	137	151	"Diseases & Disorders"	"DNA repair gene polymorphisms, such as those of XRCC3 and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to carcinogenesis."
"PA"	19096231	7	"XPD Asn312Asn"	11	24	"SNP & Sequence variations"	"cervical squamous cell carcinoma"	62	94	"Diseases & Disorders"	"Similarly, XPD Asn312Asn (AA) reduced the risk of cervical or cervical squamous cell carcinoma."
"NA"	19096231	8	"XRCC3 Thr241Met"	18	33	"SNP & Sequence variations"	"cervical carcinoma"	55	73	"Diseases & Disorders"	"No association of XRCC3 Thr241Met or XPD Lys751Gln and cervical carcinoma was found."
"FA"	19096231	6	"His1104His"	156	166	"SNP & Sequence variations"	"cervical squamous cell carcinoma"	97	129	"Diseases & Disorders"	"Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes."
"PA"	19096231	6	"Asp1104Asp"	26	36	"SNP & Sequence variations"	"cervical squamous cell carcinoma"	97	129	"Diseases & Disorders"	"Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or cervical squamous cell carcinoma compared to His1104Asp or His1104His genotypes."
"PA"	17460184	3	"polymerase gamma"	79	95	"Genes & Molecular Sequences"	"premature aging"	170	185	"Diseases & Disorders"	"Much of this data has been correlative, until recently with the development of polymerase gamma deficient mice which accumulate high levels of mtDNA mutations and show a premature aging phenotype, that a more causative role has been proposed."
"PA"	19092840	2	"TNFSF4 haplotypes"	47	64	"Genes & Molecular Sequences"	"SLE"	159	162	"Diseases & Disorders"	"A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE)."
"PA"	19092840	2	"TNFSF4 haplotypes"	47	64	"Genes & Molecular Sequences"	"systemic lupus erythematosus"	129	157	"Diseases & Disorders"	"A recent study demonstrated the association of TNFSF4 haplotypes located in the upstream region with risk for or protection from systemic lupus erythematosus (SLE)."
"PA"	19092840	4	"TNFSF4"	19	25	"Genes & Molecular Sequences"	"SLE"	31	34	"Diseases & Disorders"	"The association of TNFSF4 with SLE was replicated in all the sets except Spain."
"PA"	19092840	0	"OX40L"	27	32	"Genes & Molecular Sequences"	"systemic lupus erythematosus"	67	95	"Diseases & Disorders"	"Replication of the TNFSF4 (OX40L) promoter region association with systemic lupus erythematosus."
"PA"	19092840	8	"TNFSF4"	101	107	"Genes & Molecular Sequences"	"SLE"	131	134	"Diseases & Disorders"	"This first replication study confirms the association of genetic variation in the upstream region of TNFSF4 with susceptibility to SLE."
"SA"	17123723	9	"NPTN"	27	31	"Genes & Molecular Sequences"	"schizophrenia"	77	90	"Diseases & Disorders"	"These results suggest that NPTN may be involved in genetic susceptibility to schizophrenia."
"PA"	17123723	5	"rs3826047"	59	68	"SNP & Sequence variations"	"schizophrenia"	328	341	"Diseases & Disorders"	"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia."
"PA"	17123723	5	"rs3840846"	48	57	"SNP & Sequence variations"	"schizophrenia"	328	341	"Diseases & Disorders"	"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia."
"PA"	17123723	5	"rs3743500"	73	82	"SNP & Sequence variations"	"schizophrenia"	328	341	"Diseases & Disorders"	"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia."
"PA"	17123723	5	"NPTN"	116	120	"Genes & Molecular Sequences"	"schizophrenia"	328	341	"Diseases & Disorders"	"The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in schizophrenia."
"PA"	17906500	0	"interleukin 22 receptor"	92	115	"Genes & Molecular Sequences"	"Chronic rhinosinusitis with nasal polyps"	0	40	"Diseases & Disorders"	"Chronic rhinosinusitis with nasal polyps is associated with decreased expression of mucosal interleukin 22 receptor."
"PA"	17906500	11	"IL-22R1"	0	7	"Genes & Molecular Sequences"	"CRSsNP"	55	61	"Diseases & Disorders"	"IL-22R1 mRNA was expressed in 100% of the controls and CRSsNP."
"PA"	17906500	12	"IL-22R1"	9	16	"Genes & Molecular Sequences"	"recalcitrant CRSwNP"	60	79	"Diseases & Disorders"	"However, IL-22R1 was only expressed in 55% of patients with recalcitrant CRSwNP."
"SA"	17906500	17	"IL-22R1"	57	64	"Genes & Molecular Sequences"	"CRSwNP"	92	98	"Diseases & Disorders"	"Further research is needed to determine the potential of IL-22R1 as a therapeutic target in CRSwNP."
"FA"	17906500	13	"IL22R1"	24	30	"Genes & Molecular Sequences"	"CRSsNP"	104	110	"Diseases & Disorders"	"Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP."
"PA"	17906500	13	"IL22R1"	24	30	"Genes & Molecular Sequences"	"recalcitrant CRSwNP"	59	78	"Diseases & Disorders"	"Additionally, levels of IL22R1 were significantly lower in recalcitrant CRSwNP compared to controls and CRSsNP."
"SA"	17906500	16	"IL-22R1"	107	114	"Genes & Molecular Sequences"	"CRSwNP"	43	49	"Diseases & Disorders"	"Failure of medical and surgical therapy in CRSwNP is associated with significantly decreased expression of IL-22R1."
"PA"	19110009	3	"Fetuin-A"	0	8	"Genes & Molecular Sequences"	"vascular stiffness"	79	97	"Diseases & Disorders"	"Fetuin-A is a calcification inhibitor and correlates negatively with increased vascular stiffness in dialysis patients."
"PA"	19110009	13	"fetuin-A"	5	13	"Genes & Molecular Sequences"	"aortic stiffness"	60	76	"Diseases & Disorders"	"Male fetuin-A SerSer carriers demonstrate particularly high aortic stiffness, possibly implying a status of increased cardiovascular risk."
"PA"	19110009	4	"fetuin-A"	4	12	"Genes & Molecular Sequences"	"vascular calcification"	95	117	"Diseases & Disorders"	"The fetuin-A polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated vascular calcification in dialysis patients."
"PA"	19110611	2	"EGFR"	0	4	"Genes & Molecular Sequences"	"pancreatic adenocarcinoma"	24	49	"Diseases & Disorders"	"EGFR gene expression in pancreatic adenocarcinoma cells significantly surpassed that in normal pancreatic cells."
"PA"	19110611	0	"epidermal growth factor"	8	31	"Genes & Molecular Sequences"	"pancreatic carcinoma"	139	159	"Diseases & Disorders"	"Role of epidermal growth factor gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of pancreatic carcinoma."
"PA"	19110611	3	"EGF"	62	65	"Genes & Molecular Sequences"	"pancreatic cancer"	127	144	"Diseases & Disorders"	"On the other hand, AA genome and A allele polymorphism in the EGF gene nucleotide pair G-A 61 is a significant risk factor for pancreatic cancer."
